glp 1 agonist clinical trials efficacy results from clinical comparing different GLP‐1 Agonists for Pediatric Psychopharmacology:
Description
255 GLP-1(7-36) stimulates the release of paracrine glucagon inhibitory factors by activating GLP-1R on -cells and -cells
Watson KT, Wroolie TE, Tong G, Foland-Ross LC, Frangou S, Singh M, et al
Report No.: NCT06541509
Making it unclear if drinking green tea or yerba mate has a significant effect on GLP-1 levels in humans
However, there is no official link between these marketed patches and FDA-approved GLP-1 therapies
